Compile Data Set for Download or QSAR
maximum 50k data
Found 209 of affinity data for UniProtKB/TrEMBL: Q89535
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450562(CHEMBL4162598)
Affinity DataIC50:  2.30E+3nMAssay Description:Inhibition of RSV Long fusion protein L138F mutant assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450549(CHEMBL4174690)
Affinity DataIC50:  2.56E+3nMAssay Description:Inhibition of RSV Long fusion protein L138F mutant assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276950(CHEMBL4160323)
Affinity DataEC50:  1.00E+5nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276951(CHEMBL4172317)
Affinity DataEC50:  7.90nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276952(CHEMBL4172993)
Affinity DataEC50:  221nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276953(CHEMBL4160615)
Affinity DataEC50:  140nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276955(CHEMBL4174062)
Affinity DataEC50:  5nMAssay Description:Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillographyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276956(CHEMBL4159228)
Affinity DataEC50:  12nMAssay Description:Inhibition of DGAT1 in rat adipose tissue assessed as reduction in triacylglycerol synthesisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276957(CHEMBL4175427)
Affinity DataEC50:  10nMAssay Description:Inhibition of DGAT1 in human HuTu80 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276958(CHEMBL4164110)
Affinity DataEC50:  5.42E+3nMAssay Description:Inhibition of DGAT1 in human liver microsomesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276959(CHEMBL4161686)
Affinity DataEC50:  4nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276960(CHEMBL4173452)
Affinity DataEC50:  12nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276961(CHEMBL4165762)
Affinity DataEC50:  4.30nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276962(CHEMBL4171983)
Affinity DataEC50:  2.41E+3nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276968(CHEMBL4176374)
Affinity DataEC50:  3nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276969(CHEMBL4164254)
Affinity DataEC50:  17nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276970(CHEMBL4163349)
Affinity DataEC50:  54nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276971(CHEMBL4167137)
Affinity DataEC50:  78nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276972(CHEMBL4167556)
Affinity DataEC50:  180nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276973(CHEMBL4170928)
Affinity DataEC50:  290nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276979(CHEMBL4160708)
Affinity DataEC50:  53nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276980(CHEMBL4168630)
Affinity DataEC50:  93nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276997(CHEMBL4177424)
Affinity DataEC50:  100nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276998(CHEMBL4171885)
Affinity DataEC50:  25nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50277006(CHEMBL4164014)
Affinity DataEC50:  3nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50277007(CHEMBL4165109)
Affinity DataEC50:  1.07E+3nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50277008(CHEMBL4175725)
Affinity DataEC50:  7nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50277047(CHEMBL4165530)
Affinity DataEC50:  88nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50277048(CHEMBL4161267)
Affinity DataEC50:  35nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50277049(CHEMBL4169195)
Affinity DataEC50:  1nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50277050(CHEMBL4160710)
Affinity DataEC50:  75nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50277051(CHEMBL4169599)
Affinity DataEC50:  3.40nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50088178(BMS-433771 | CHEMBL243876)
Affinity DataEC50:  28nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50277052(CHEMBL4172133)
Affinity DataEC50:  2nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50276954(CHEMBL4177457)
Affinity DataEC50:  5.40nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450522(CHEMBL4163788)
Affinity DataEC50:  150nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450523(CHEMBL4174923)
Affinity DataEC50:  39nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450524(CHEMBL4160231)
Affinity DataEC50:  41nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450525(CHEMBL4175600)
Affinity DataEC50:  7nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450526(CHEMBL4162982)
Affinity DataEC50:  27nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450527(CHEMBL4167240)
Affinity DataEC50:  14nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450534(CHEMBL4176580)
Affinity DataEC50:  37nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450538(CHEMBL4170626)
Affinity DataEC50:  10nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450539(CHEMBL4168325)
Affinity DataEC50:  14nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450540(CHEMBL4167426)
Affinity DataEC50:  25nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450541(CHEMBL4161097)
Affinity DataEC50:  12nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450542(CHEMBL4170204)
Affinity DataEC50:  540nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450543(CHEMBL4162290)
Affinity DataEC50:  280nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450544(CHEMBL4167039)
Affinity DataEC50:  71nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50450545(CHEMBL4163590)
Affinity DataEC50:  26nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 209 total ) | Next | Last >>
Jump to: